Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro

European Journal of Pharmacology

Volumn 312, Issue 1, 1996, Pages 89-96

  Alves, Alessandra C ^a   Pires, Ana L A ^a   Cruz, Hermenegildo N ^a   Serra, Magda F ^a   Diaz, Bruno L ^a   Cordeiro, Renato S B ^a   Lagente, Vincent ^b   Martins, Marco A ^a   E Silva, Patrícia M R ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Migration, in vitro; Peritoneal eosinophil; Phosphodiesterase inhibition; 2 Adrenoceptor agonist

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; DIBUTYRYL CYCLIC GMP; FORSKOLIN; LEUKOTRIENE B4; MILRINONE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; SALBUTAMOL; SALMETEROL; SIGUAZODAN; THROMBOCYTE ACTIVATING FACTOR; ZAPRINAST;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CHEMOTAXIS; EOSINOPHIL; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; RAT;

EID: 0030593745     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00357-3     Document Type: Article

References (41)

1. Barnes, P., 1995, Cyclic nucleotides and phosphodiesterases and airway function, Eur. J. Pharmacol. 8, 457.
2. Beavo, J.A., M. Conti and R.J. Heaslip, 1994, Multiple cyclic nucleotide phosphodiesterase, Mol. Pharmacol. 46, 399.
3. Botana, L.M and D.W. MacGlashan, 1994, Differential effects of cAMP-elevating drugs on stimulus-induced cytosolic calcium changes in human basophils, J. Leukoc. Biol. 55, 798.
4. Dent, G., M.A. Giembycz, K.F. Rabe and P.J. Barnes, 1991, Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-simulated respiratory burst by 'type IV'-selective PDE inhibitors, Br. J. Pharmacol. 103, 1339.
5. Derian, C.K., R.J. Santulli, P.E. Rao, H.F. Solomon and J.A. Barret, 1994, Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators, J. Immunol. 154, 308.
6. 2 cyclic AMP inhibits pleural exudation and leucocyte influx caused by antigen in rats, Eur. J. Pharmacol. 296, 173.
7. Djukanovic, R., P. Howarth, B. Vrugt, S. Wilson, A. Semper, P. Bradding, R. Aalbers and S. Holgate, 1995, Determinants of asthma severity. Int. Arch. Allergy Immunol. 107, 389.
8. Elwood, W., J. Sun, P.J. Barnes, M.A. Giembycz and K.F. Chung, 1995, Inhibition of allergen-induced lung esinophilia by type-III and combined type III-and IV-selective phosphodiesterase inhibitors in Brown-Norway rats, Inflamm. Res. 44, 83.
9. Frigas, E. and G.J. Gleich, 1986, The eosinophil and the pathology of asthma, J. Allergy Clin. Immunol. 77, 527.
10. Gartner, I., 1980, Separation of human eosinophils in density gradients of polyvinylpyrrolidine-coated silica gel (Percoll), Immunology 40, 133.
11. Gleich, G.J., S. Motojima, E. Frigas, G.M. Kephart, T. Fujisawa and L.P. Kravis, 1987, The eosinophilic leukocyte and the pathology of fatal bronchial asthma: evidence for pathologic heterogeneity, J. Allergy Clin. Immunol. 80, 412.
12. Hall, I.P., 1993, Isoenzyme selective phosphodiesterase inhibitors: potential clinical uses, Br. J. Clin. Pharmac. 35, 1.
13. Harvath, L., J.D. Robins, A.A. Russel and K.B. Seamon, 1991, cAMP and human neutrophil chemotaxis. Elevation of cAMP differentialy affects chemotactic responsiveness, J. Immunol. 146, 224.
14. Hatzelmann, A., H. Tenor and C. Schudt, 1995, Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions, Br. J. Pharmacol. 114, 821.
15. Kaliner, M. and K.F. Austen, 1974, Cyclic nucleotides and modulation of effector systems of inflammation, Biochem. Pharmacol. 23, 763.
16. Kita, H., R.I. Abu-Ghazaleh, G.J. Gleich and R.T. Abraham, 1991, Regulation of Ig-induced eosinophil degranulation by adenosine 3',5'-cyclic monophosphate, J. Immunol. 146, 2712.
17. Kroegel, C., J.A. Warner, J.R. Virchow and H. Matthys, 1994, Pulmonary immune cells in health and disease: the eosinophil leucocyte (part II), Eur. Respir. J. 7, 743.
18. Lagente, V., I. Moodley, S. Perrin, G. Mottin and J.L. Junien, 1994, Effects of isoenzyme-selective phosphodiesterase inhibitors on eosinophil infiltration in the guinea-pig lung, Eur. J. Pharmacol. 255, 253.
19. Lagente, V., M.P. Pruniaux, J.L. Junien and I. Moodley, 1995, Modulation of cytokine-induced eosinophil infiltration in guinea-pig airways by selective phosphodiesterase inhibitors, Am. J. Respir. Crit. Care Med. 151, 1720.
20. Martins, M.A., A. Etienne, C. Soulard, M.T. Domingo and P. Braquet, 1989, Chemotactic effect of PAF on peritoneal eosinophil from normal rats, Braz. J. Med. Biol. Res. 22, 1151.
21. Mengelers, H.J., T. Maikoe, L. Brinkman, B. Hooibrink, J.-W.J. Lammers and L. Koenderman, 1994, Immunophenotyping of eosinophils recovered from blood and BAL of allergic asthmatics, Am. J. Respir. Crit. Care Med. 149, 345.
22. Muñoz, N.M., K.F. Rabe, A.J. Vita, K. McLlister, D. Mayer, M. Weiss and A.R. Leff, 1995, Paradoxical blockade of beta adrenergically mediated inhibition of stimulated eosinophil secretion by salmeterol, J. Pharmacol. Exp. Ther. 273, 850.
23. Nagai, H., H. Takeda, T. Iwama, S. Yamaguchi and H. Mori, 1995, Studies on anti-allergic action of AH 21-132, a novel isozyme-selective phosphodiesterase inhibitor in airways, Jpn. J. Pharmacol. 67, 149.
24. Newsholme, S.J. and L. Schwartz, 1993, cAMP-specific phosphodiesterase inhibitor, rolipram, reduces eosinophil infiltration evoked by leukotrienes or by histamine in guinea pig conjuntiva, Inflammation 17, 25.
25. Nicholson, C.D. and M. Shahid, 1994, Inhibitors of cyclic nucleotide phosphodiesterases isoenzymes, their potential utility in the therapy of asthma, Pulm. Pharmacol. 7, 1.
26. Plaut, M., G. Marone and E. Gillespie, 1983, The role of cyclic AMP in modulating cytotoxic T lymphocytes. II. Sequential changes during culture in responsiveness of cytotoxic lymphocytes to cyclic AMP-active agents, J. Immunol. 131, 2945.
27. Richards, K.L. and J. McCullough, 1984, A modified microchamber method for chemotaxis and chemokinesis, Immunol. Commun. 13, 49.
28. Robicsek, S., D.K. Blanchard, J. Djeu, J.J. Krzanowski, A. Szentivanyi and J.B. Polson, 1991, Multiple high-affinity cAMP phosphodiesterases in human T-lymphocytes, Biochem. Pharmacol. 42, 869.
29. Sanjar, S., S. Aoki, A. Kristersson, D. Smith and J. Morley, 1990, Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs, Br. J. Pharmacol. 99, 679.
30. Santing, R.E., C.G. Olymulder, K. Van der Molen, H. Meurs and J. Zaagsma, 1995, Phosphodiesterase inhibitors reduce bronchial hyper-reactivity and airway inflammation in unrestrained guinea pigs, Eur. J. Pharmacol. 275, 75.
31. Sedgwick, J.B., W.J. Calhoun, R.F. Vrtis, M.E. Bates, P.K. MaAllister and W.W. Busse, 1992, Comparison of airway and blood eosinophil function after in vivo allergen challenge, J. Immunol. 149, 3710.
32. Shute, J., 1993, Signal transduction mechanisms in human eosinophils, Clin. Exp. Allergy 23, 713.
33. Silva, P.M.R., M.A. Martins, M.C.R. Lima, A.C. Alves, B.L. Diaz and R.S.B. Cordeiro, 1992, Pharmacological modulation of the late eosinophilia induced by antigen in actively sensitized rats, Int. Arch. Allergy Immunol. 98, 355.
34. Souness, J.E., C.M. Carter, B.K. Diocee, G.A. Hassal, L.J. Wood and N.C. Turner, 1991, Characterisation of guinea-pig eosinophil phsophosdiesterase activity: assessment of its involvement in regulating superoxide generation, Biochem. Pharmacol. 42, 937.
35. Sullivan, P., S. Bekir, Z. Jaffar, C. Page, P. Jeffery and J. Costello, 1994, Anti-inflammatory effects of low dose oral theophylline in atopic asthma, Lancet 343, 1006.
36. Torphy, T.J. and B.J. Undem, 1991, Phosphodiesterase inhibitors: new opportunities for the treatment of asthma, Thorax 46, 512.
37. Turner, N.C., L.J. Wood, F.M. Burns, T. Gueremy and J.E. Sousness, 1993, The effect of cyclic AMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages, Br. J. Pharmacol. 108, 876.
38. Undem, B.J., T.J. Torphy, D. Goldman and F.H. Chilton, 1990, Inhibition of adenosine 3':5'-monophosphate of eicosanoid and platelet-activating factor biosynthesis in the mouse PT-18 mast cell. J. Biol. Chem. 265, 6750.
39. Vegesna, R.V.K. and J. Diamond, 1984, Effects of isoproterenol and forskolin on tension, cyclic AMP levels, and cyclic AMP dependent protein kinase activity in bovine coronary artery, Can. J. Physiol. Pharmacol. 62, 1116.
40. Walsh, G.M., A.J. Wardlaw and A.B. Kay, 1993, Eosinophil accumulation, secretion and activation, in: Immunopharmacology of Eosinophils, eds. H. Smith and R. Cook (Academic Press, San Diego, CA) p. 73.
41. 2-adrenergic receptors on eosinophils. Binding and functional studies. Am. Rev. Respir. Dis. 141, 1446.